Objectives: The effect of berberis vulgaris juice on plasma level of hormonal-metabolic parameters, plasma level and gene expression of PPAR-ϓ in patients with benign breast tumor (2)Design:A randomized controlled clinical trial.(3) Setting and conduct: 80 patients with benign breast tumor will be randomly divided into either intervention or control group. In this study, observers in laboratory and nurses for distributing the beverages will be blinded. (4)Participants: The inclusion criteria: Histopathological confirmed benign breast; 15-45 years old; Tendency to corporation in study; Completing informed consent form; Passing atleast 2 year from diagnosing disease; BMI less than the ratio of 35 kilogram to squared meter; Moderately active; Lack of menopause. Exclusion criteria: Energy intake range out of 500-3500; History of consumption cigarette in recent 1 year before diagnosing the disease; Acute chronic disease like other cancers, Cardiovascular disease, Renal disease, Liver disease, Hyperthyroidism and other hormonal disorder before diagnosing the disease (pcos, type 1 diabetes, Hypoglycemia, Adrenal gland malfunction ); Having any kind of bleeding & trauma by self reporting or physician; History of other benign neoplasms; Pregnancy and lactation; Consumption of drugs like glucocorticoids, Blood anticoagulants, Epilepsy-related drugs, HRTs, Fish oil supplements more than 2000 mg per day.(5) Intervention: Subjects in intervention group will receive 480 ml berberis vulgaris juice in lunch & dinner meal. Also In control group subjects will receive 480 ml placebo both in lunch & dinner meal. (6) Main outcome measures (variables): Measuring plasma levels of hormonal-metabolic parameters (IGF-1, Insulin, C-peptide, FBS, IGFBP-1, IGFBP-3) and plasma level and gene expression of PPAR-gamma at baseline & endpoint of intervention